,Word,Count
0,ards,104
1,pneumonia,76
2,hydroxychloroquine,70
3,convalescent plasma,38
4,intensive care unit,33
5,anxiety,30
6,depression,27
7,cytokine storm,26
8,respiratory failure,25
9,quality of life,24
10,mental health,24
11,pandemic,23
12,safety,19
13,healthcare workers,18
14,mechanical ventilation,18
15,pregnancy,17
16,azithromycin,16
17,critical care,15
18,mortality,14
19,acute lung injury,13
20,treatment,13
21,prevention,13
22,stress,13
23,telemedicine,13
24,inflammation,12
25,favipiravir,12
26,serology,12
27,exercise,12
28,epidemiology,12
29,tocilizumab,12
30,anticoagulation,12
31,mesenchymal stem cells,11
32,children,11
33,cancer,11
34,physical activity,11
35,personal protective equipment,11
36,prophylaxis,10
37,lung ultrasound,10
38,antibodies,10
39,social isolation,10
40,coronavirus infections,10
41,vaccine,10
42,rehabilitation,9
43,nutrition,9
44,chloroquine,9
45,infection,9
46,quarantine,9
47,sleep,9
48,ivermectin,9
49,covid 19 pandemic,9
50,thrombosis,9
51,colchicine,9
52,virus,9
53,confinement,9
54,ruxolitinib,9
55,severe acute respiratory syndrome coronavirus 2 (sars cov 2),9
56,prognosis,9
57,anosmia,9
58,prevalence,9
59,covid 19 drug treatment,8
60,egypt,8
61,health care workers,8
62,immunotherapy,8
63,prone position,8
64,artificial intelligence,8
65,intubation,8
66,vitamin d,8
67,cell therapy,8
68,mesenchymal stromal cells,8
69,intensive care,8
70,sars covid 2,8
71,corona virus infection,7
72,surgery,7
73,pulmonary embolism,7
74,severe acute respiratory syndrome,7
75,diagnosis,7
76,immunity,7
77,coronavirus disease,7
78,acute respiratory failure,7
79,rt pcr,6
80,interferon,6
81,antiviral agents,6
82,burnout,6
83,corona,6
84,randomized controlled trial,6
85,stem cells,6
86,risk factors,6
87,psychological impact,6
88,radiotherapy,6
89,gm csf,6
90,anakinra,6
91,cognition,6
92,resilience,6
93,incidence,6
94,farmagen,6
95,clinical trial,6
96,biomarkers,6
97,mindfulness,6
98,hypoxia,6
99,outcome,6
100,il 6,6
101,novagenix,6
102,vitamin c,6
103,ecmo,6
104,cytokine release syndrome,6
105,post traumatic stress disorder,6
106,viral infection,6
107,obesity,6
108,hypoxemia,6
109,efficacy,6
110,virus diseases,6
111,2019 novel coronavirus,5
112,diabetes,5
113,viral load,5
114,severe pneumonia,5
115,antibody,5
116,microbiome,5
117,child,5
118,heparin,5
119,chemoprophylaxis,5
120,respiratory distress syndrome,5
121,dyspnea,5
122,seroprevalence,5
123,inhaled nitric oxide,5
124,cardiovascular disease,5
125,angiotensin converting enzyme inhibitors,5
126,anti inflammatory,5
127,pain,5
128,lopinavir/ritonavir,5
129,telehealth,5
130,coagulopathy,5
131,oxygen,5
132,elderly,5
133,hospitalization,5
134,msc,5
135,covid 19 infection,5
136,cohort,5
137,stroke,5
138,invasive mechanical ventilation,5
139,ventilation,4
140,critical illness,4
141,covid 19 vaccine,4
142,older adults,4
143,psychological distress,4
144,critically ill,4
145,respiratory disease,4
146,igg,4
147,hypertension,4
148,ambulatory,4
149,covid 19 convalescent plasma,4
150,severe acute respiratory syndrome (sars) pneumonia,4
151,2019 novel coronavirus pneumonia,4
152,containment,4
153,pediatric,4
154,renin angiotensin system,4
155,sepsis,4
156,endoscopy,4
157,machine learning,4
158,corticosteroids,4
159,saliva,4
160,2019 novel coronavirus disease,4
161,antiviral,4
162,corona virus disease,4
163,pandemics,4
164,dexamethasone,4
165,epidemic,4
166,post traumatic stress,4
167,survival,4
168,infectious diseases,4
169,randomized clinical trial,4
170,nitazoxanide,4
171,post exposure prophylaxis,4
172,outcomes,4
173,coagulation,4
174,social media,4
175,eating habits,4
176,outpatient,4
177,infection control,4
178,health personnel,4
179,immunogenicity,4
180,fatigue,4
181,virtual care,4
182,viral pneumonia,4
183,physiotherapy,4
184,cognitive behavioral therapy,4
185,monoclonal antibody,4
186,acute kidney injury,4
187,gargle,3
188,outbreak,3
189,low dose radiotherapy,3
190,pandemia,3
191,self isolation,3
192,kaletra,3
193,dose escalation,3
194,losartan,3
195,loneliness,3
196,ascorbic acid,3
197,aspirin,3
198,olfactory disorders,3
199,general population,3
200,lockdown,3
201,zinc,3
202,older people,3
203,ozone therapy,3
204,otorhinolaryngology,3
205,severe acute respiratory syndrome (sars),3
206,lifestyle,3
207,health,3
208,baricitinib,3
209,bcg,3
210,blood pressure,3
211,myocarditis,3
212,brain,3
213,cohort study,3
214,chloroquine phosphate,3
215,cholecalciferol,3
216,mesenchymal stem cell,3
217,methylprednisolone,3
218,ecg,3
219,radiation,3
220,questionnaire,3
221,education,3
222,yoga,3
223,effectiveness,3
224,mobile health,3
225,remdesivir,3
226,public health,3
227,complications,3
228,emergency department,3
229,prognostic factors,3
230,povidone iodine,3
231,primary care,3
232,pre exposure prophylaxis,3
233,coronavirus disease 2019 (covid 19),3
234,myocardial infarction,3
235,myocardial injury,3
236,nigella sativa,3
237,remote monitoring,3
238,sars cov2 virus,3
239,noninvasive ventilation,3
240,sars cov infection,3
241,novel coronavirus pneumonia,3
242,lung injury,3
243,sars (severe acute respiratory syndrome),3
244,das181,3
245,d dimer,3
246,pathophysiology,3
247,lymphoma,3
248,cardiac function,3
249,cardiac surgery,3
250,malnutrition,3
251,melatonin,3
252,cardiovascular diseases,3
253,risk stratification,3
254,maraviroc,3
255,caregivers,3
256,non invasive ventilation,3
257,coronavirus 2019,3
258,ct,3
259,fibrosis,3
260,fear,3
261,nitric oxide,3
262,respiratory tract diseases,3
263,online learning,3
264,ali,3
265,adults,3
266,immune response,3
267,angiotensin receptor blockers,3
268,hiv,3
269,taste disorders,3
270,transmission,3
271,interferon beta 1a,3
272,survey,3
273,high flow nasal cannula,3
274,healthcare professionals,3
275,symptoms,3
276,acute respiratory distress syndrome (ards),3
277,telmisartan,3
278,trained immunity,3
279,ansun,3
280,telerehabilitation,3
281,heart failure,3
282,humoral immunity,3
283,hyperbaric oxygen,3
284,vertical transmission,3
285,triage,3
286,infectious disease,3
287,adipose derived mesenchymal stem cells,3
288,healthcare,3
289,hemostasis,3
290,interleukin 6,3
291,anesthesia,3
292,healthcare worker,3
293,mesoblast,2
294,acute myocarditis,2
295,transpulmonary thermodilution,2
296,clinical features,2
297,echocardiography,2
298,clinical outcome,2
299,infectious respiratory diseases,2
300,covid 2019,2
301,memorial sloan kettering cancer center,2
302,child psychiatry,2
303,inflammatory lung conditions,2
304,mediterranean diet,2
305,traditional chinese medicine,2
306,inflammatory lung disease,2
307,transcranial magnetic stimulation,2
308,face mask,2
309,remote,2
310,chronic pain,2
311,recovery,2
312,plasma,2
313,messenger rna,2
314,transplanted patients,2
315,chronic inflammatory rheumatism,2
316,eculizumab,2
317,neuroinflammation,2
318,transplantation,2
319,hfnc,2
320,mesenchymal,2
321,viral,2
322,family members,2
323,covid 19;,2
324,rct,2
325,famotidine,2
326,transfusion,2
327,remestemcel l,2
328,inflammasome,2
329,magnetic resonance imaging,2
330,repurposed drug,2
331,early rehabilitation,2
332,respiratory tract infections,2
333,respiratory virus,2
334,thymalfasin,2
335,nivolumab,2
336,acute hypoxemia,2
337,mas,2
338,rheumatoid arthritis,2
339,human,2
340,thromboprophylaxis,2
341,risk factor,2
342,cardiovascular risk factor,2
343,critically ill patient,2
344,rivaroxaban,2
345,innate immune memory,2
346,thrombin generation,2
347,food insecurity,2
348,cardiopulmonary resuscitation,2
349,critically ill patients,2
350,perinatal mortality,2
351,e health,2
352,angiotensin converting enzyme inhibitor,2
353,thymosin alpha 1,2
354,cellular therapy,2
355,physician,2
356,mechanical ventilator,2
357,immune support,2
358,amniotic fluid,2
359,chest ct scan,2
360,chest ct,2
361,neutrophil extracellular traps,2
362,extravascular lung water,2
363,covid19 vaccine,2
364,physical function,2
365,respiratory distress,2
366,anaesthesia,2
367,"respiratory distress syndrome, adult",2
368,news,2
369,eating disorder,2
370,tnf,2
371,respiratory function tests,2
372,respiratory illness,2
373,respiratory infection,2
374,physical activity level,2
375,respiratory insufficiency,2
376,viral respiratory illnesses,2
377,hepatocellular carcinoma,2
378,ebselen,2
379,aki,2
380,extracorporeal membrane oxygenation,2
381,ncov 2019,2
382,electronic nose,2
383,adverse drug event,2
384,contact tracing,2
385,prone positioning,2
386,contact subject,2
387,multicenter,2
388,conjunctivitis,2
389,multi organ failure,2
390,immunosuppression,2
391,electrical impedance tomography,2
392,environmental exposure,2
393,postpartum depression,2
394,nebulization,2
395,uninfected,2
396,venous thromboembolism,2
397,mrna 1273 vaccine,2
398,computed tomography,2
399,mrna 1273,2
400,proton pump inhibitors,2
401,covid 19 convalescent plasma treatment,2
402,venous ultrasound,2
403,adaptive,2
404,young children,2
405,continuous positive airway pressure,2
406,microbiome metabolic therapy,2
407,adolescent,2
408,nac,2
409,nafamostat,2
410,coronavirus disease 19 (covid 19),2
411,precision medicine,2
412,vasculitis,2
413,coronavirus 2,2
414,hospitalized patients,2
415,young adults,2
416,coronaviridae infections,2
417,ade,2
418,pregnant women,2
419,endotracheal intubation,2
420,immunology,2
421,encephalitis,2
422,prep,2
423,vector vaccine,2
424,adult,2
425,veno venous ecmo,2
426,adult respiratory distress syndrome,2
427,immunomodulator,2
428,nasopharyngeal swab,2
429,probiotic,2
430,movement disorders,2
431,umifenovir,2
432,covid 19 diagnostic testing,2
433,exercises,2
434,misinformation,2
435,type 2 diabetes,2
436,turkish society,2
437,mirna,2
438,hyposmia,2
439,mindfulness meditation,2
440,qualitative research,2
441,efficiency,2
442,high/moderate risk of transmission,2
443,households,2
444,high risk,2
445,post intensive care syndrome,2
446,exosome,2
447,invasive ventilation,2
448,covid 19 virus,2
449,trial,2
450,covid 19 virus infection,2
451,covid 19 virus testing,2
452,immune system,2
453,microclots,2
454,rt pcr sars cov 2,2
455,treatment resistance,2
456,pulmonary vascular permeability index,2
457,"pneumonia, viral",2
458,evolution,2
459,pulmonary rehabilitation,2
460,umbilical cord,2
461,covid 19 disease,2
462,ultrasonography,2
463,post exposure prophylaxis (pep),2
464,escape mutation,2
465,covid 19 epidemic,2
466,ad5,2
467,ptsd,2
468,veterans,2
469,moderna,2
470,immunoassay,2
471,covid 19 phase i,2
472,eicosanoids,2
473,ageusia,2
474,pocus,2
475,covid 19 prophylaxis,2
476,pulmonary function,2
477,uc mscs,2
478,pneumonitis,2
479,mmt,2
480,cognitive impairment,2
481,ino,2
482,follow up,2
483,hemodialysis,2
484,cross sectional study,2
485,systemic lupus erythematosus,2
486,il 1,2
487,severity,2
488,doctors,2
489,glycan,2
490,intervention study,2
491,bariatric surgery,2
492,hydroxy chloroquine,2
493,bacillus calmette guérin vaccination,2
494,observational study,2
495,ayurveda,2
496,singapore,2
497,sirolimus,2
498,laryngoscope,2
499,aviptadil,2
500,granulocyte macrophage colony stimulating factor (gm csf),2
501,oxygen saturation,2
502,antibody test,2
503,occupational exposure,2
504,"antibodies, monoclonal, humanized",2
505,severe disease,2
506,igm,2
507,nursing care,2
508,seroconversion,2
509,biobank,2
510,seroepidemiology,2
511,genetic factors,2
512,serological testing,2
513,decision making,2
514,deep learning,2
515,liver cirrhosis,2
516,bi 655066,2
517,anti pd1,2
518,deep vein thrombosis,2
519,deep venous thrombosis,2
520,severe,2
521,severe acute respiratory infection,2
522,volatile organic compounds,2
523,ace2,2
524,anti sars cov 2 plasma,2
525,pancreatic islet transplantation,2
526,nucleocapsid,2
527,sleep disorders,2
528,diabetes mellitus,2
529,vitamin d3,2
530,artesunate,2
531,spinal cord injury,2
532,antigen presentation,2
533,jak inhibitor,2
534,ivig,2
535,intravascular access,2
536,arb,2
537,statin,2
538,stellate ganglion,2
539,diagnostics,2
540,ifn beta 1b,2
541,health workers,2
542,isolation,2
543,apc,2
544,apache ii,2
545,digital intervention,2
546,2019 ncov infection,2
547,digital,2
548,health professionals,2
549,students,2
550,spi 1005,2
551,healthcare personnel,2
552,acalabrutinib,2
553,specificity,2
554,sleep quality,2
555,lactoferrin,2
556,oximetry,2
557,smartwatch,2
558,laboratory,2
559,gut microbiota,2
560,academic performance,2
561,outpatients,2
562,abbv 066,2
563,asymptomatic infection,2
564,social distancing,2
565,asymptomatic,2
566,3 d,2
567,kb109,2
568,hcq,2
569,solid organ transplantation,2
570,soliris,2
571,kaleido biosciences,2
572,kaleido,2
573,taste,2
574,leukemia,2
575,lung disease,2
576,sars cov 2 pneumonia,2
577,drug therapy,2
578,sars cov 2 vaccine,2
579,lung cancer,2
580,testing,2
581,btk inhibitor,2
582,bromhexine,2
583,lqts,2
584,brainstem,2
585,lower respiratory tract disease,2
586,low molecular weight heparin,2
587,sars pneumonia,2
588,sars virus,2
589,low level laser therapy,2
590,satisfaction,2
591,patient reported outcomes,2
592,lung diseases,2
593,sars cov,2
594,tele yoga therapy,2
595,sars coronavirus 2,2
596,insomnia,2
597,acute coronary syndrome,2
598,oncology,2
599,"safety care, covid, primary care, organization of care",2
600,therapeutic treatment,2
601,dysgeusia,2
602,dysautonomia,2
603,sample collection,2
604,angiotensin receptor blocker,2
605,lung ultrasonography,2
606,sarcopenia,2
607,sarilumab,2
608,therapeutic anticoagulation,2
609,canakinumab,2
610,sars coronavirus,2
611,drug interaction,2
612,immunoglobulins,2
613,humoral response,2
614,cytosorb,2
615,self compassion,2
616,passive immunization,2
617,screening,2
618,d dimers,2
619,data analytics,2
620,hydrocortisone,2
621,pathogens,2
622,biomarker,2
623,sensitivity,2
624,sedation,2
625,anti inflammatory effects,2
626,cytokines,2
627,gastrointestinal,2
628,double filtration plasmapheresis,1
629,disability,1
630,hyperbaric chamber,1
631,elective,1
632,hydrochloroquine,1
633,elisa test,1
634,duration of intensive care stay,1
635,elisa,1
636,host directed therapeutic,1
637,early extubation,1
638,electroporation,1
639,disease outbreak,1
640,emergency visits,1
641,early discharge,1
642,huaier granule,1
643,electrophysiology,1
644,disability physical,1
645,emdr,1
646,disease containment strategies,1
647,electronic medical record,1
648,double blind randomized control trial,1
649,early cpap ventilation,1
650,human dental pulp stem cells,1
651,effector t cells,1
652,ecmo vv,1
653,emergency,1
654,emergency medical technicians,1
655,dosing,1
656,emergency treatment,1
657,differentiation treatment,1
658,difficulty weaning from mechanical ventilation,1
659,dyspareunia,1
660,early  warning scores,1
661,digital cardiac counseling,1
662,digital health,1
663,dilitazem,1
664,emergency physicians,1
665,emergency medicine,1
666,"economic burden, covid 19 pandemic",1
667,emergency care,1
668,emergency medical service,1
669,human centered design,1
670,emergency laparoscopy,1
671,dipyridamole,1
672,direct laryngoscope,1
673,hospitals,1
674,dutasteride,1
675,human amniotic fluid,1
676,hpv associated oropharyngeal squamous cell carcinoma,1
677,emergency departement,1
678,economic modeling,1
679,hsct,1
680,early learning intervention,1
681,educational learning games,1
682,hydroxychloroquine (hcq),1
683,dose response,1
684,eicosanoid storm,1
685,drug resistant pneumonia,1
686,disulfiram,1
687,hydroxychloroquine sulfate,1
688,hydrogen peroxide,1
689,diuretics,1
690,hplc/uv diode array,1
691,ehealth,1
692,dn tnf,1
693,egyptian,1
694,dna methylation,1
695,hypercoagulability,1
696,humanistic care,1
697,dna vaccine,1
698,dornase alfa,1
699,hypoxaemic,1
700,household,1
701,egd,1
702,doppler echo,1
703,humans,1
704,docosahexaenoic acid,1
705,household contacts of a person infected with sars cov 2,1
706,donor,1
707,drug,1
708,echocardiogram,1
709,distress,1
710,human umbilical cord derived mesenchymal stem cells,1
711,disease progression,1
712,drugs,1
713,disinfectatnts,1
714,hydrogen/oxygen mixed gas,1
715,hydrogen oxygen generator with neburlizer,1
716,human factors study,1
717,hyper inflammation,1
718,hydroxycholoroquine,1
719,early phase treatment,1
720,elderly people,1
721,hydroxychloroquine/darunavir/ritonavir,1
722,elderly patients,1
723,duration of hospital stay,1
724,duration of artificial ventilation,1
725,dissonance,1
726,eicosapentaenoic acid ethyl ester,1
727,drug use,1
728,eeg,1
729,distant learning,1
730,eating behaviours,1
731,host directed treatment,1
732,effect of drugs,1
733,ecological momentary intervention (emi),1
734,ecmo va,1
735,doxycycline,1
736,dpp4,1
737,elastance,1
738,eidd 2801,1
739,ecological momentary assessment (ema),1
740,health personnel attitude,1
741,emergent surgery,1
742,hospitalized children,1
743,functionality,1
744,functioning,1
745,galidesivir,1
746,gamma,1
747,gamma globulins,1
748,heart disease,1
749,gas exchange,1
750,heart conditions,1
751,hearing loss,1
752,gastrointestinal function,1
753,"gender, caregiving, covid 19, couple relations",1
754,gene therapy,1
755,general affect,1
756,general health questionnare,1
757,healthy volunteers,1
758,general practice,1
759,generalized anxiety,1
760,healthy carrier,1
761,healthcare workers needs,1
762,genetic polymorphism,1
763,genetic risk score,1
764,genetics,1
765,geriatric,1
766,healthcare workers emotional distress,1
767,geriatrics,1
768,hypercoagulability state,1
769,functional status,1
770,functional score,1
771,frailty,1
772,hemophagocytic lymphohistiocytosis (hlh),1
773,follow up studies,1
774,hemodynamic chracteristics,1
775,food service,1
776,football,1
777,hyperbaric oxygen therapy,1
778,hemoadsorption,1
779,foregone care,1
780,formoterol,1
781,hematology,1
782,fourth trimester,1
783,frailty syndrome,1
784,functional outcomes,1
785,hematological malignancies,1
786,hematologic malignancy,1
787,french guiana,1
788,french national cohort,1
789,frontline,1
790,helmet nonivasive ventilation,1
791,helmet interface niv,1
792,frontline healthcare workers,1
793,frozen embryos,1
794,function,1
795,functional impairment,1
796,healthcare workers burn out,1
797,hyperinflammation,1
798,gfap protein,1
799,hyperimmune plasma,1
800,haemodialysis,1
801,haemoglobin concentration,1
802,hand disinfection,1
803,hand wash,1
804,handwashing,1
805,hcm,1
806,healthcare professional's health,1
807,healthcare professional,1
808,hcw,1
809,heallthy lifestyle,1
810,health behavior change,1
811,health benefits,1
812,gynecologic cancer,1
813,health care,1
814,health care personnel,1
815,health care professionals,1
816,health care provider,1
817,health status,1
818,health coaching,1
819,health disparities,1
820,health disparity,1
821,health staff,1
822,health education,1
823,health services research,1
824,hacor score,1
825,gut microbiome,1
826,giant cell arteritis,1
827,gm csf monoclonal antibody,1
828,gilteritinib,1
829,global longitudinal strain,1
830,glucocorticoids,1
831,glucose control,1
832,glucose measurements,1
833,glue ear,1
834,glutathione,1
835,glycemic control,1
836,glycine,1
837,glycosylated ferritin,1
838,healthcare system reorganization,1
839,gm csf neutralizing scfv,1
840,gut lung axis,1
841,healthcare staff,1
842,gm csf receptor alpha,1
843,gns561,1
844,gp iib/iiia inhibitor,1
845,group treatment,1
846,gs 5734,1
847,gsk3196165,1
848,guduchi ghan vati,1
849,guided,1
850,gum arabic,1
851,gustatory disorders,1
852,fnirs,1
853,fmri,1
854,fluvoxamine,1
855,esomeprazole,1
856,hood,1
857,environmental stress,1
858,honey,1
859,environmental stressor,1
860,enzalutamide,1
861,homecare,1
862,epidemics,1
863,epigallocatechin 3 gallate,1
864,equity,1
865,home situation,1
866,escalation,1
867,home rehabilitation,1
868,environment contamination,1
869,esophageal pressure,1
870,esophagogastroduodenoscopy,1
871,home isolation,1
872,essential oils,1
873,etdrs visual acuity,1
874,"ethnic minority, health disparity, epidemiology, biomarker discovery, public health, bame, morbidity, mortality, covid 19, sars cov 2",1
875,ethnicity,1
876,ethyl epa,1
877,etoposide,1
878,home cooking,1
879,home confinement,1
880,environmental contamination,1
881,enoxaparin,1
882,home care,1
883,endoscopic ultrasound,1
884,emerging adulthood,1
885,emotional freedom technique,1
886,emotional regulation,1
887,hospitalised,1
888,hospital workers,1
889,hospital staff,1
890,hospital personnel,1
891,hospital healthcare workers,1
892,encephalopathy,1
893,endocrinology,1
894,endoscopic retrograde cholangiopancreatography,1
895,endosomal toll like receptor 3,1
896,hope,1
897,endothelial,1
898,endotheliopathy,1
899,hypogonadism,1
900,endothelium,1
901,endotracheal tube,1
902,hospital admission,1
903,endotracheal tube obstruction,1
904,endovascular procedures,1
905,hospital,1
906,energy expenditure,1
907,enhanced ppe,1
908,ett,1
909,exchange transfusion,1
910,fluoxetine,1
911,fibrinogen,1
912,hfno,1
913,fatty liver disease,1
914,herbal medicine,1
915,feasibility,1
916,fecal microbiota transplantation,1
917,ferritin,1
918,herbal drug,1
919,fertility preservation,1
920,fetus,1
921,herbal,1
922,fever,1
923,fibrinogenesis,1
924,hyperviscosity,1
925,fibrinolysis,1
926,filmarray pneumonia plus panel,1
927,henry ford hospital,1
928,financial impacts,1
929,firefighters,1
930,first responders,1
931,fit test,1
932,flourishing,1
933,flt3,1
934,flu,1
935,fluid therapy,1
936,fatigability,1
937,fatality rate,1
938,exclusive breastfeeding,1
939,"exposure, occupational",1
940,home based rehabilitation,1
941,exercise benefits and barriers,1
942,hlh,1
943,higher education students,1
944,exercise capacity,1
945,exercise endurance,1
946,exercise tolerance,1
947,expanded access program,1
948,expert consensus,1
949,exposure,1
950,exposure therapy,1
951,extreme phenotypes,1
952,high flow nasal cannula (hfnc),1
953,eye,1
954,eye movement desensitisation and reprocessing,1
955,facial trauma,1
956,facilities and services utilization,1
957,factors,1
958,families,1
959,familly,1
960,family,1
961,high intensity physical activity,1
962,family child care home providers,1
963,high flow nasal oxygenation,1
964,exosomes,1
965,zinc sulfate,1
966,differential gene expression,1
967,asymptomatic positive,1
968,atorvastatin,1
969,athlete,1
970,atazanavir,1
971,atabay,1
972,at1,1
973,at home treatment,1
974,asymptomatic infections,1
975,atypical acute respiratory distress syndrome,1
976,asthma,1
977,assay,1
978,aspergillus,1
979,aspergillosis,1
980,aspecific respiratory symptomatology,1
981,asp2215,1
982,attention deficit hyperactivity disorder,1
983,atyr1923,1
984,bacille calmette guérin,1
985,avoidance,1
986,"b cell non hodgkin‟s lymphoma involving spinal cord, and/or leptomeningeal space",1
987,açaí berry,1
988,azithromycine,1
989,axial spondyloarthritis,1
990,awareness,1
991,awake proning,1
992,auxora,1
993,autism spectrum disorder,1
994,autopsy,1
995,autonomic nervous system,1
996,autologous adipose derived stem cells (admscs) for covid 19 [nct id not yet assigned],1
997,autoantibodies,1
998,auto inflammatory diseases,1
999,auto immune diseases,1
1000,artificial nutrition,1
1001,arterial thromboembolism,1
1002,artemisinin,1
1003,antiinflammatory,1
1004,antirheumatic agents,1
1005,antiretroviral therapy,1
1006,antiparasitic agents,1
1007,antioxidant,1
1008,antimicrobial stewardship,1
1009,antimalarials,1
1010,antihypertensive medications,1
1011,arrhythmic manifestations,1
1012,antihypertensive agents,1
1013,antigen test,1
1014,antigen,1
1015,antibody titer,1
1016,antibody testing,1
1017,antibody test kit,1
1018,antithrombotic,1
1019,antithrombotic treatments,1
1020,antiviral therapy,1
1021,anxiety disorder,1
1022,anxiety disorders,1
1023,anxious,1
1024,apheresis,1
1025,apilimod dimesylate,1
1026,apolactoferrin,1
1027,app,1
1028,apple watch,1
1029,aprv,1
1030,arbidol,1
1031,arbs,1
1032,arfc,1
1033,arn,1
1034,arrhythmia,1
1035,b cell non hodgkin‟s lymphoma involving the brain,1
1036,bangladesh,1
1037,antibody and cell mediated immune responses,1
1038,body mass index,1
1039,burkholderia,1
1040,budesonide,1
1041,breastfeeding guidelines,1
1042,breast milk,1
1043,brain injury,1
1044,brain health,1
1045,body image,1
1046,c1 esterase inhibitor,1
1047,body fluids,1
1048,blood samples,1
1049,blood plasma,1
1050,blood phenotyping,1
1051,blood drop,1
1052,blood diseases,1
1053,c reactive protein,1
1054,c5a receptors,1
1055,barrier box,1
1056,cancer surgery,1
1057,cardiac surgical waiting list,1
1058,cardiac injury,1
1059,cardiac damage,1
1060,cardiac arrhythmias covid,1
1061,cardiac arrest,1
1062,cancer survivor,1
1063,cancer patients,1
1064,caesalpinia spinosa,1
1065,cancer diagnosis,1
1066,cancer care,1
1067,camostat mesylate,1
1068,camostat,1
1069,calcium release activated calcium channel (crac) inhibitors,1
1070,calcium channel blockers,1
1071,blood cord,1
1072,blood biomarkers,1
1073,blockers of angiotensin receptor,1
1074,behavior and social functioning in children,1
1075,betadine,1
1076,betacoronavirus,1
1077,belgium,1
1078,behcet's disease,1
1079,behaviour change,1
1080,behavior intentions,1
1081,bedside ultrasound,1
1082,blinded,1
1083,bcg vaccine,1
1084,bcg vaccination,1
1085,bbv152,1
1086,basic body awareness therapy,1
1087,barrier measures,1
1088,barrier device,1
1089,bevacizumab,1
1090,bhv 3500,1
1091,bidirectional oxygenation,1
1092,big data,1
1093,bio psycho social and occupational factors,1
1094,biohaven,1
1095,biological risk factor,1
1096,biological specimens,1
1097,biology of infectious agent,1
1098,biomarkers of inflammation,1
1099,biopsychosocial intervention,1
1100,biosensors,1
1101,biosynex,1
1102,bipolar depression,1
1103,birth experience,1
1104,black cummin,1
1105,black seed,1
1106,antibody formation,1
1107,"antibodies, neutralizing",1
1108,cardiometabolic phenotype,1
1109,acute hypoxic respiratory failure,1
1110,acute respiratory tract infection,1
1111,acute respiratory syndrome,1
1112,acute respiratory infection,1
1113,acute myeloid leukemia,1
1114,acute kidney injury (aki),1
1115,acute ischemic stroke related to large vessel occlusion,1
1116,acute hypoxemic respiratory failure (ahrf),1
1117,"acute stress, pharmacological impact",1
1118,acute hypoxemic respiratory failure,1
1119,acute dyspnea,1
1120,acute distress respiratory syndrome,1
1121,"acute appendicitis, covid 19",1
1122,acute appendicitis,1
1123,acurate kidney injury,1
1124,acute stress,1
1125,acz885,1
1126,advanced suturing skills,1
1127,adjuvant,1
1128,adult stem cells,1
1129,adolescents and young adults(aya),1
1130,adolescents,1
1131,adolescent; mental health; depression; suicide,1
1132,adolescence,1
1133,adn,1
1134,adipose,1
1135,ad5 ncov,1
1136,adherence to epidemiological interventions (npis),1
1137,adenovirus vector,1
1138,adenovirus,1
1139,addiction is a common disease,1
1140,adaptive immunity,1
1141,adapted physical activity,1
1142,activities of daily living,1
1143,active monitoring,1
1144,active learning,1
1145,2019 ncov (mrna 1273),1
1146,25 hydroxyvitamin d3,1
1147,2019ncov,1
1148,2019 novel coronavirus infection,1
1149,2019 novel coronavirus (2019 n cov),1
1150,2019 new coronavirus (2019ncov),1
1151,2019 ncov pneumonia,1
1152,2019 ncov (covid 19),1
1153,activated t cells,1
1154,20 187,1
1155,20 185,1
1156,20 176,1
1157,19 382,1
1158,19,1
1159,17 409,1
1160,25 oh cholecalciferol,1
1161,3d printable valve,1
1162,"50,000iu",1
1163,abx464,1
1164,access to care,1
1165,access to health care,1
1166,accuracy,1
1167,accute breathing failure,1
1168,ace 2,1
1169,ace inhibitors,1
1170,ace inhibitors drugs,1
1171,ace inibitors,1
1172,ace2 tmprss2,1
1173,acei,1
1174,"acei, arb, dri",1
1175,acetylcysteine,1
1176,acquisition protocol,1
1177,advanced coronavirus disease 2019,1
1178,adverse effects of drugs,1
1179,antibiotics saving,1
1180,angiotensin converting enzyme 2 (ace2),1
1181,angiotensin receptor blocker (arb),1
1182,angiotensin receptor blockade,1
1183,angiotensin receptor antagonists,1
1184,angiotensin receptor antagonist,1
1185,angiotensin ii receptor blockers,1
1186,angiotensin ii receptor blocker,1
1187,angiotensin converting enzyme 2,1
1188,anitgen testing,1
1189,angiotensin converting enzyme,1
1190,angiotensin 2 receptor blockers,1
1191,anger,1
1192,anemia,1
1193,anatomy,1
1194,analogue,1
1195,angiotensin receptor blocker and ace inhibitors drugs,1
1196,anluohuaxian,1
1197,adverse reactions,1
1198,"anti infective agents, local",1
1199,antibiotics,1
1200,anti viral,1
1201,anti sars cov 2 convalescent plasma,1
1202,anti sars cov 2 antibody,1
1203,anti malarials,1
1204,"anti inflammatory, and antioxidant ons",1
1205,anti infective agents,1
1206,anorexia nervosa,1
1207,anti il 1,1
1208,anti hypertensive drugs (acei's/arb),1
1209,anti c5ar,1
1210,anti bacterial agents,1
1211,anti angiogenics,1
1212,anti androgen,1
1213,amr101,1
1214,amoxicillin clavulanate,1
1215,aml,1
1216,aggrenox,1
1217,airway,1
1218,air pollution,1
1219,air contamination,1
1220,aids,1
1221,ai therapeutics,1
1222,aging in place,1
1223,aged subjects,1
1224,aminoacetic acid,1
1225,african american,1
1226,affordable housing,1
1227,aerosol box,1
1228,aerosol,1
1229,aerobic exercises,1
1230,aecopd,1
1231,airway closer,1
1232,airway closure,1
1233,airway management,1
1234,airway opening pressure,1
1235,airway pressure release ventilation,1
1236,alcohol,1
1237,alcohol use disorder,1
1238,ali/ards,1
1239,alkylating drug,1
1240,all cause mortality,1
1241,all on four,1
1242,allogeneic hybrid treg/th2cells,1
1243,allostim,1
1244,almitrine,1
1245,alpha 1 receptor antagonist,1
1246,alveolar macrophage,1
1247,alzheimer disease,1
1248,cardio vascular outcomes,1
1249,cardiomyopathy,1
1250,dietary intake,1
1251,"covid 19, ards, hydroxychloroquine, azithromycin,tdp",1
1252,"covid 19, non pharmacological interventions (npis), loneliness, worry, rumination, depression, anxiety",1
1253,"covid 19, mpv/plt, pneumonia",1
1254,"covid 19, early gerontologic healthcare",1
1255,"covid 19, dornase alpha",1
1256,"covid 19, deferoxamine",1
1257,"covid 19, ards, targeted temperature management",1
1258,"covid 19,",1
1259,"covid 19, social distancing, loneliness, worry, rumination, depression, anxiety",1
1260,covid 19 virus disease,1
1261,covid 19 treatment,1
1262,covid 19 symptoms,1
1263,covid 19 surveillance smart wearable device,1
1264,covid 19 serotherapy,1
1265,covid 19 rt pcr test,1
1266,"covid 19, sars cov 2, convalescent plasma",1
1267,"covid 19, sras cov 2",1
1268,cpdi,1
1269,"covid19, biomarkers",1
1270,cpap,1
1271,cp,1
1272,covid‐19 pneumonia,1
1273,covid_19,1
1274,"covid19, prediction scores, icu admission, death, tripod.",1
1275,"covid19, forecasting",1
1276,covid19 pneumonia,1
1277,covid 19; sars cov2 infection,1
1278,covid19 pediatric,1
1279,covid19 igg,1
1280,covid infection,1
1281,covid ards,1
1282,"covid 2019, ,t cells, ifn type1",1
1283,"covid 2019 ,infection, b38 cap , bacterial ace2 receptors  like enzyme , rhace226",1
1284,covid 19 related stress,1
1285,covid 19 related severe pneumonia,1
1286,covid 19 positive,1
1287,"coronavirus, susceptibility, transmission, hcw",1
1288,cough,1
1289,cost savings,1
1290,cost of care,1
1291,cost effectiveness,1
1292,corticosteroid,1
1293,coronovirus,1
1294,"coronavirus, sars cov 2, covid 19, cardiovascular",1
1295,covid 19 messaging study,1
1296,coronavirus pandemic,1
1297,coronavirus induced disease 2019,1
1298,coronavirus epidemic,1
1299,coronavirus electronic registry geriatrics best practices,1
1300,coronavirus disease 2019 incidence,1
1301,coronavirus disease 2019 (covid19),1
1302,counter attitudinal therapy,1
1303,couple relationship,1
1304,cov 2,1
1305,covd 19,1
1306,covid   19,1
1307,covid  19,1
1308,covid 19   sars cov2,1
1309,covid 19 cardiac,1
1310,covid 19 cardiopulmonary immunological impact,1
1311,covid 19 confinement,1
1312,covid 19 containment will change drugs practices,1
1313,covid 19 containment will changes access to care,1
1314,covid 19 ctl,1
1315,covid 19 diagnostic,1
1316,covid 19 infection or paucy symptomatic carriage,1
1317,covid 19 ivermectin aspirin dexametasone enoxaparin,1
1318,covid 19 knowledge and perceptions,1
1319,cpap therapy,1
1320,cranial nerves,1
1321,coronavirus 19,1
1322,detection tests,1
1323,"diabetes mellitus, type 2",1
1324,dhodh inhibition,1
1325,dfv890,1
1326,dexmedetomidine,1
1327,detroit,1
1328,deterioration,1
1329,dermatitis,1
1330,diagnosis improvement,1
1331,depressive symptoms,1
1332,depressive disorders,1
1333,depistage,1
1334,dentistry,1
1335,dentist,1
1336,dental students,1
1337,diabetic ketoacidosis (dka),1
1338,diagnosis test,1
1339,cri,1
1340,diaphragm ultrasound,1
1341,dietary habits,1
1342,dietary diversity,1
1343,diet quality,1
1344,diet intervention,1
1345,diet,1
1346,diarrhea,1
1347,dialyzable leukocyte extract,1
1348,diagnostic,1
1349,dialysis,1
1350,diagnostic value,1
1351,diagnostic test,1
1352,diagnostic strategy,1
1353,diagnostic management,1
1354,diagnostic (qrt pcr or serology) methods,1
1355,dental stem cell banking,1
1356,dental hygiene,1
1357,dementia,1
1358,ct angiography,1
1359,cytof assay,1
1360,cynk 001,1
1361,cyclin g1,1
1362,cybersexuality,1
1363,curriculum design,1
1364,ct scan,1
1365,crs,1
1366,delirium,1
1367,crrt,1
1368,cronovirus,1
1369,crohn's disease,1
1370,critical disease,1
1371,"critical care, public health",1
1372,crisis intervention,1
1373,cytokine,1
1374,cytokine adsorption,1
1375,cytokine release storm,1
1376,cytokine release syndrom,1
1377,cytokine release syndrome (crs),1
1378,cytokine storm sindrome,1
1379,cytokine storm syndrome,1
1380,d2000 cartridge,1
1381,daily function,1
1382,dapagliflozin,1
1383,darunavir,1
1384,dass 21,1
1385,data specimen repository,1
1386,days alive at home,1
1387,dcm,1
1388,deferoxamine,1
1389,defibrotide,1
1390,coronavirus disease 19(covid 19),1
1391,coronary artery disease,1
1392,cardiovascular death,1
1393,cholangitis,1
1394,chronic pathology,1
1395,chronic musculoskeletal pain,1
1396,chronic low back pain,1
1397,chronic inflammation,1
1398,chronic diseases,1
1399,chronic conditions,1
1400,chlorpromazine,1
1401,cirrhosis,1
1402,chloroquine diphosphate,1
1403,chlorhexidine gluconate,1
1404,chinese medicine,1
1405,chinese herbal medicine,1
1406,chinese,1
1407,chime,1
1408,ciclesonide,1
1409,citrate,1
1410,clungene,1
1411,clinical presentation,1
1412,clofazimine,1
1413,clinical trial matching,1
1414,clinical trial (stepped wedge),1
1415,clinical trajectories,1
1416,clinical symptoms,1
1417,clinical study,1
1418,clinical care pathway,1
1419,ck0802,1
1420,clinical care,1
1421,clinical,1
1422,clinic stay,1
1423,classification,1
1424,clarithromycin,1
1425,ckd 5,1
1426,childhood obesity,1
1427,childbirth,1
1428,child health,1
1429,ccr5,1
1430,cell transplantation,1
1431,celiac disease,1
1432,ceftriaxone,1
1433,ceftaroline,1
1434,cd risc 25,1
1435,ccr5 antagonist,1
1436,cbt i,1
1437,child care provider stress,1
1438,cause of death,1
1439,castem,1
1440,carriage,1
1441,caring contacts,1
1442,cardiovascular risk,1
1443,cardiovascular prevention,1
1444,cells,1
1445,cellular immunity,1
1446,cellular response,1
1447,center for disease control and prevention,1
1448,cepi,1
1449,cf101,1
1450,cgm,1
1451,chadox1 ncov19,1
1452,changes in pain intensity,1
1453,characteristics,1
1454,chat intervention,1
1455,chemokines,1
1456,chemotherapy,1
1457,chest radiography,1
1458,chest x ray,1
1459,chilblains,1
1460,child care provider informational support,1
1461,clots,1
1462,clustering,1
1463,corona virus disease 19 (covid 19),1
1464,conestat alfa,1
1465,consultation,1
1466,conjunctival swabs,1
1467,conjunctival swab,1
1468,congenital sars infection,1
1469,congenital heart disease,1
1470,confusion,1
1471,computerized cognitive training,1
1472,continuity of patient care,1
1473,computed tomography (ct),1
1474,complications during icu stay,1
1475,complication,1
1476,complicated acute appandicitis,1
1477,complementary therapies,1
1478,complement system,1
1479,containment measures,1
1480,continuous glucose monitoring,1
1481,cm4620,1
1482,conventional oxygen treatment (cot),1
1483,corona virus disease 19,1
1484,cord blood,1
1485,coranavirus,1
1486,coping,1
1487,copd,1
1488,convolutional neural network architectures,1
1489,"convalescent plasma,covid,sars cov  2",1
1490,continuous renal replacement therapy,1
1491,convalescent plasma transfusion,1
1492,convalescent plasma therapy,1
1493,convalescent plasma doses,1
1494,convalescent antibodies,1
1495,convalescent,1
1496,continuous venovenous hemodialysis,1
1497,complement inhibition,1
1498,complement,1
1499,compensatory reserve index,1
1500,cobicistat,1
1501,cognitive decline,1
1502,cognitive behavioural therapy,1
1503,cognitive behavioral training,1
1504,cognitive behavioral intervention,1
1505,codex (high dimensional microscopy) analysis,1
1506,coded record form,1
1507,coalition brazil v 2019,1
1508,comorbidity,1
1509,coagulation disorders,1
1510,coagulapathy,1
1511,co trimoxazole,1
1512,co morbidities,1
1513,co infection,1
1514,cnns,1
1515,cognitive outcome,1
1516,coinfection,1
1517,college students,1
1518,colon cancer screening,1
1519,colonization,1
1520,colonoscopy,1
1521,combination therapy,1
1522,combined simultaneous (cosi) endoscopy,1
1523,communication,1
1524,community acquired pneumonia,1
1525,community acquired pneumonia (cap),1
1526,community care patients,1
1527,community engagement,1
1528,community health,1
1529,community health workers,1
1530,community programs,1
1531,comorbidities,1
1532,hypoxemic acute respiratory failure,1
1533,ketamine,1
1534,hypoxia negative,1
1535,resource allocation,1
1536,respondent driven sampling,1
1537,respiratory viruses,1
1538,respiratory viral infection,1
1539,respiratory viral diseases,1
1540,respiratory rate,1
1541,respiratory protective devices,1
1542,respiratory physiotherapy,1
1543,respiratory muscles,1
1544,respiratory multiplex pcr,1
1545,respiratory mechanics,1
1546,respiratory infections,1
1547,respiratory exercises,1
1548,respiratory distress/failure,1
1549,respiratory decompensation,1
1550,respiratory complication,1
1551,response,1
1552,resting energy expenditure,1
1553,restrictive syndrom,1
1554,risankizumab,1
1555,rna virus infections,1
1556,rna vaccine,1
1557,rna extraction,1
1558,ritonavir,1
1559,risk prediction,1
1560,risk of overdose on de confinment,1
1561,ribonucleoside,1
1562,resveratrol,1
1563,rhinf α,1
1564,rheumatoid,1
1565,rhdnase1,1
1566,retrospective case review,1
1567,retraining,1
1568,retinoic acid,1
1569,respirators,1
1570,resistant starch,1
1571,robotics,1
1572,resiliency,1
1573,reinfection,1
1574,rehabilitative medicine,1
1575,regulatory t cells,1
1576,registry study,1
1577,regional anesthesia,1
1578,refugees,1
1579,red light,1
1580,red blood cells,1
1581,recovery of function,1
1582,reconsolidation,1
1583,recombinase aided amplification assay,1
1584,recombinant novel coronavirus vaccine,1
1585,recipient,1
1586,reason action approch,1
1587,reanimation,1
1588,relapse prevention,1
1589,relocation,1
1590,remodeling,1
1591,renessans,1
1592,resident wellness,1
1593,"research trends, covid 19, pandemic, interventional studies, observational studies",1
1594,reprogram,1
1595,reorganisation of care,1
1596,renin angiotensin system (ras),1
1597,renin angiotensin aldosterone system (raas),1
1598,renal replacement therapy,1
1599,remote medical surveillance,1
1600,renal oxygenation,1
1601,renal function decline,1
1602,renal damage,1
1603,renal circulation,1
1604,rems,1
1605,remote trial,1
1606,robot assisted percutaneous cardiovascular intervention,1
1607,rosuvastatin,1
1608,postoperative care,1
1609,saturation,1
1610,seizure/epilepsy,1
1611,sedentary behaviour,1
1612,sedentary behavior,1
1613,sedative use; sedative sparing,1
1614,sedative shortages,1
1615,security,1
1616,secukinumab,1
1617,score,1
1618,scleroderma,1
1619,schools,1
1620,schooling,1
1621,school closings,1
1622,school children,1
1623,school,1
1624,scarce resource allocation,1
1625,self assessment application,1
1626,self efficacy,1
1627,senegal,1
1628,serology sars cov 2,1
1629,severe acute respiratory syndrome (sars) cov 2 virus,1
1630,severe acute respiratory syndrome   coronavirus 2,1
1631,serum therapy,1
1632,serum,1
1633,seroprevalence study,1
1634,"serology,",1
1635,serological tests,1
1636,sense of smell disorders,1
1637,serological assay,1
1638,serodiagnosis,1
1639,serine protease inhibitor,1
1640,serelogic response,1
1641,sequelae,1
1642,septorhioplasty,1
1643,saudi arabia,1
1644,"sars virus, sars cov 2, covid 19, health personnel",1
1645,rotational thromboelastometry,1
1646,sars v2,1
1647,"sars cov 1, covid, coronavirus, convalescent plasma, plasma",1
1648,sars co v 2,1
1649,sargramostim,1
1650,sarcoidosis,1
1651,sar cov2,1
1652,salivary sampling,1
1653,saliva collection,1
1654,saliva based serology,1
1655,safety net programs,1
1656,saccharin transit time (stt),1
1657,s1p1 ligand,1
1658,rural community,1
1659,running subcuticular sutures,1
1660,rt pcr covid 19,1
1661,rotem,1
1662,sars cov 2 antibodies,1
1663,sars cov 2 coronavirus,1
1664,sars cov 2 exposed subjects,1
1665,"sars cov 2, surgery",1
1666,sars cov2; cannabidiol,1
1667,sars cov2 rhino pharyngeal carriage,1
1668,sars cov2 neuroinvasiveness,1
1669,sars cov2 infection,1
1670,sars cov clearance,1
1671,sars cov 2;covid 19;voluntary respondents;web based survey,1
1672,"sars cov 2, intensive care",1
1673,sars cov 2 re infection,1
1674,"sars cov 2, genetics",1
1675,"sars cov 2,",1
1676,sars cov 2 virus,1
1677,sars cov 2 viral load,1
1678,sars cov 2 serologies,1
1679,sars cov 2 rt pcr,1
1680,real world data,1
1681,reactogenicity,1
1682,rdrp inhibitors,1
1683,predictive medicine,1
1684,prison,1
1685,primary prevention,1
1686,primary pci,1
1687,preventive medicine,1
1688,preventive measures,1
1689,prevent covid 19 infection,1
1690,pressure volume curve,1
1691,presence of covid 19 symptoms,1
1692,prenatal care,1
1693,preload dependency,1
1694,prehabilitation,1
1695,pregnancy; sars cov 2; covid 19,1
1696,pregnancy loss,1
1697,prednisone,1
1698,predictor,1
1699,pro resolving,1
1700,procalcitonin,1
1701,proctology,1
1702,proning,1
1703,prostacyclins,1
1704,propranolol,1
1705,propolis,1
1706,prophylaxie,1
1707,prophylactic,1
1708,proper diet,1
1709,prone position ventilation,1
1710,procurement,1
1711,progression,1
1712,prognostics,1
1713,prognostic score,1
1714,prognostic factor,1
1715,prognostic epigenetics,1
1716,prognostic,1
1717,predictive modeling,1
1718,predictive factors,1
1719,ravulizumab,1
1720,prediction score,1
1721,povidone iodine decolonization,1
1722,povidone   iodine,1
1723,povidone,1
1724,povidine iodine (pvp i),1
1725,poverty,1
1726,posttraumatic stress disorder,1
1727,postprandial metabolism,1
1728,postponed elective surgery,1
1729,postponed care,1
1730,postpartum period,1
1731,postpartum health,1
1732,postpartum,1
1733,postoperative outcome,1
1734,postoperative consultation,1
1735,postoperative complications,1
1736,powered air purifying respirator,1
1737,ppe adherence,1
1738,ppi,1
1739,pre operative nutritional counseling,1
1740,prediction,1
1741,predictability,1
1742,precision oncology,1
1743,precarious,1
1744,pre surgical screening,1
1745,pre operative psychological assessment,1
1746,pre exposure,1
1747,practice modification,1
1748,pre emptive therapy,1
1749,prazosin,1
1750,praise,1
1751,pragmatic trial,1
1752,pragmatic clinical tria,1
1753,pragmatic,1
1754,"protease inhibitor, antiretroviral drug, covid 19",1
1755,proteases,1
1756,protection,1
1757,protection equipment,1
1758,quarantine depression,1
1759,quantra,1
1760,quantitative ct lung function imaging,1
1761,quanrantine,1
1762,qualitative study,1
1763,quadriceps muscle,1
1764,"qt interval, ventricular repolarization",1
1765,qsofa,1
1766,qatar,1
1767,pyronaridine,1
1768,pyramax,1
1769,pvp i,1
1770,pulse,1
1771,pulmozyme,1
1772,pulmonary vasodilators,1
1773,quarenteen,1
1774,quarentine,1
1775,quellor,1
1776,randomized controlled study,1
1777,ras system,1
1778,ras blockers,1
1779,ras,1
1780,rapid tests,1
1781,rapid detection,1
1782,rapa 501 allo,1
1783,randomized controlled,1
1784,quit to win,1
1785,randomized,1
1786,ralescore,1
1787,radiologic changes,1
1788,radiographic assessment of lung edema,1
1789,radiation therapy,1
1790,rabeprazole,1
1791,pulmonary ultrasound,1
1792,pulmonary thrombosis,1
1793,pulmonary telerehabilitation,1
1794,psychiatry,1
1795,psychological support,1
1796,psychological rehabilitation,1
1797,psychological counseling,1
1798,psychological,1
1799,psychologic changes,1
1800,psycho social impact,1
1801,psychiatric traumatic stress disorder,1
1802,psychosocial,1
1803,psychiatric population,1
1804,psychiatric disturbances,1
1805,psoriatic arthritis,1
1806,protective immunity,1
1807,protective effect,1
1808,protection from respiratory infecton,1
1809,psychology,1
1810,psychosocial impairment,1
1811,pulmonary physiotherapy,1
1812,pulmonary compromise,1
1813,pulmonary injury,1
1814,pulmonary infection,1
1815,pulmonary gas exchange : respiratory tract diseases,1
1816,pulmonary exercise,1
1817,pulmonary disease,1
1818,pulmonary damage,1
1819,pulmonary blood mass,1
1820,psychosocial stress,1
1821,pulmonary arteries,1
1822,pulmonary,1
1823,public space,1
1824,public health surveillance,1
1825,public health response,1
1826,pt pcr screening test,1
1827,severe acute respiratory syndrome coronavirus,1
1828,severe acute respiratory syndrome coronavirus 2 infection,1
1829,severe acute respiratory syndrome of upper respiratory tract,1
1830,tyrosine kinase inhibitor,1
1831,urinary incontinence,1
1832,urban settings,1
1833,urban,1
1834,upper extremity,1
1835,unvonluntary commitment,1
1836,university students,1
1837,universal screening,1
1838,unexpected cardiac arrest,1
1839,undergraduate,1
1840,uncommunicative,1
1841,ultrasound,1
1842,ultraprotective ventilation,1
1843,ultrafiltration rate,1
1844,ultomiris,1
1845,ulcerative colitis,1
1846,urological surgery,1
1847,usability,1
1848,vaccination,1
1849,vasculature,1
1850,venous thromboembolic disease,1
1851,vedolizumab,1
1852,vdd,1
1853,vazegepant,1
1854,vasopressor,1
1855,vasoactive intestinal polypeptide,1
1856,vascular surgical procedures,1
1857,vaccinology,1
1858,vascepa,1
1859,value based care,1
1860,valsartan,1
1861,vagus nerve stimulation,1
1862,vagus nerve stimolation,1
1863,vagus nerve,1
1864,uc mscs treatment,1
1865,type1diabetes,1
1866,"thromboembolism, venous",1
1867,type 1 diabetes,1
1868,trained innate immunity,1
1869,train of four (tof),1
1870,tracheotomy,1
1871,tracheostomy,1
1872,tracheal intubation,1
1873,tracetogether,1
1874,topical therapy,1
1875,tomeka®,1
1876,tnf gene polymorphism,1
1877,tnf alpha,1
1878,tmpss2,1
1879,tmprss2,1
1880,tki,1
1881,titer,1
1882,thrombomodulin,1
1883,transcutaneous oximetry,1
1884,transfusion medicine,1
1885,translation and interpreting studies,1
1886,triggered acute cardiovascular events,1
1887,turkish physicians,1
1888,tuberculin test positive,1
1889,troponin,1
1890,trimethoprim/sulfamethoxazole,1
1891,triiodothyronine,1
1892,triggered myocardial infarction,1
1893,treatment sars cov 2 infection,1
1894,transplant,1
1895,treatment covid 19,1
1896,traumatic stress,1
1897,traumatic brain injury,1
1898,trauma,1
1899,transplant recipients,1
1900,transplant recipient,1
1901,ventilation induced lung injury,1
1902,ventilator,1
1903,vertical mother fetal transmission,1
1904,vessel,1
1905,wgs,1
1906,wellness,1
1907,wellbeing; covid19,1
1908,well being,1
1909,weight loss,1
1910,wechat,1
1911,web based prospective cohort study,1
1912,wearable sensor,1
1913,wearable physiological monitor,1
1914,wearable medical devices,1
1915,wearable,1
1916,washed microbiota transplantation,1
1917,warming,1
1918,waitlist,1
1919,waiting list,1
1920,whatsapp,1
1921,who adapted 6 points ordinal scale,1
1922,whole exome sequencing,1
1923,x ray,1
1924,zambia,1
1925,zadaxin,1
1926,youth smokers,1
1927,yoga stress anxiety depression wellbeing covid,1
1928,yellow fever,1
1929,xpro1595,1
1930,wuhan,1
1931,whole genome analysis,1
1932,worry,1
1933,world medicine,1
1934,workers,1
1935,work stress,1
1936,women,1
1937,whoqol bref,1
1938,voraxaze (glucarpidase),1
1939,volunteers,1
1940,voluntary agents,1
1941,viral conjunctivitis,1
1942,virology,1
1943,viral shredding,1
1944,viral pneumology,1
1945,viral genome,1
1946,viral envelope proteins,1
1947,viral cultures,1
1948,vip,1
1949,virtual clinics,1
1950,vienna,1
1951,vie scope,1
1952,videoconferencing,1
1953,videoconference,1
1954,video laryngoscope,1
1955,vibroacustic therapy,1
1956,virtual care management,1
1957,virtual peer support platforms,1
1958,volatile anesthetics,1
1959,viscoelastic assay,1
1960,vitamin d status,1
1961,vitamin d polymorphisms,1
1962,vitamin d deficiency,1
1963,vital signs,1
1964,visitation,1
1965,viscoelastic testing,1
1966,visceral surgery,1
1967,virtual treatment,1
1968,viruses,1
1969,virus specific t cell,1
1970,virucidal,1
1971,virtues,1
1972,virtual visits,1
1973,virtual tumor board,1
1974,thrombolysis,1
1975,thromboembolism risk,1
1976,severe coronavirus 2,1
1977,smell disorders,1
1978,solid tumor,1
1979,sodium nitrite,1
1980,social recovery,1
1981,social interactions,1
1982,social inequality,1
1983,social emotional learning games,1
1984,"social distancing, quarantine, isolation",1
1985,social distance,1
1986,social cognition,1
1987,soc,1
1988,snsd,1
1989,snap and sniff olfactory test,1
1990,smoking cessation,1
1991,smoking behaviors,1
1992,smoke exposure,1
1993,somatic symptom disorder,1
1994,south africa,1
1995,spatter,1
1996,sras cov 2,1
1997,stem cell research,1
1998,stem cell educator therapy,1
1999,stem cell,1
2000,static magnetic fields,1
2001,standard of care,1
2002,ssc,1
2003,squamous cell carcinoma of the neck of unknown primary,1
2004,spectra optia apheresis system,1
2005,spread dynamics,1
2006,spontaneous ventilation,1
2007,spo2,1
2008,spironolactone,1
2009,spinal cord injuries,1
2010,sperm,1
2011,smell therapy,1
2012,smartphone,1
2013,thrombin generation test,1
2014,slums,1
2015,short physical performance battery,1
2016,shock,1
2017,shine,1
2018,shared decision making,1
2019,sglt2i,1
2020,sexuality,1
2021,sex offender,1
2022,severity of disease,1
2023,severity factors,1
2024,severe respiratory distress,1
2025,severe illness,1
2026,severe ill,1
2027,severe hospitalized influenza,1
2028,severe forms,1
2029,severe covid 19,1
2030,shortness of breath,1
2031,sick leave,1
2032,sickle cell pandemic wellness,1
2033,skin,1
2034,sleep wake disorders,1
2035,sleep disturbances,1
2036,sleep disturbance scale for children,1
2037,sleep disturbance,1
2038,sleep apnea,1
2039,sledd,1
2040,sjogren's syndrome,1
2041,side effects,1
2042,six minute walk test,1
2043,sitagliptin,1
2044,sinus rinse,1
2045,single cell sequencing,1
2046,simvastatin,1
2047,silymarin,1
2048,stem cells treatment,1
2049,"stem cells, covid 19, sars cov2, wj mscs, immunomodulation,",1
2050,stemi,1
2051,stilbene,1
2052,telephone,1
2053,tele wellness service,1
2054,tele medicine,1
2055,tele intervention,1
2056,technologies,1
2057,tears,1
2058,tear fluid,1
2059,teaching methods,1
2060,tbular necrosis,1
2061,targeted therapy,1
2062,tap water,1
2063,t3,1
2064,t1d,1
2065,t regulatory cells,1
2066,t cells,1
2067,telepsychiatry,1
2068,teletherapy,1
2069,temperature,1
2070,therapeutic use,1
2071,thorax ct,1
2072,theta burst stimulation,1
2073,thermophysiology,1
2074,thermography,1
2075,therapeutics,1
2076,therapeutic vaccine,1
2077,therapeutic study,1
2078,terumo bct,1
2079,therapeutic plasma exchange,1
2080,therapeutic management,1
2081,theory of planned behavior,1
2082,tga,1
2083,text messaging,1
2084,tetrandrine,1
2085,t cell response,1
2086,t cell receptor,1
2087,t and b cell immune response,1
2088,student nurses,1
2089,supar,1
2090,suicide prevention,1
2091,substance use disorder,1
2092,substance p,1
2093,subsolid pulmonary nodules,1
2094,subsidized housing,1
2095,stroke patient/survivors,1
2096,supplementation,1
2097,"stroke , acute",1
2098,stresses,1
2099,"stress, psychological",1
2100,stress mindfulness,1
2101,stress level,1
2102,strength,1
2103,supplemental oxygen,1
2104,supportive self care,1
2105,systems biology,1
2106,symptom tracker,1
2107,systemic sclerosis,1
2108,systemic impairment,1
2109,systemic hyperinflammation,1
2110,systemic cytokine release syndrome,1
2111,synthetic antimalarial drugs (amd),1
2112,syndrome investigation,1
2113,symptom,1
2114,surgical education,1
2115,switzerland,1
2116,"suspected or proved covid 19 virus infection, current or past",1
2117,surrogate,1
2118,surgical residency,1
2119,surgical outcome,1
2120,surgical oncology,1
2121,postoperative complication,1
2122,postmenopausal,1
2123,hypoxic pulmonary vasoconstriction,1
2124,long term prognosis,1
2125,lung cancer screening,1
2126,lrti,1
2127,lrrk2,1
2128,lower respiratory tract infection,1
2129,low level light therapy,1
2130,low frequency right side stimulation,1
2131,low flow nasal cannula,1
2132,low dose radiation therapy,1
2133,low dose of il 2,1
2134,low dose lung radiotherapy,1
2135,low dose ct screening,1
2136,low dose ct scan,1
2137,low dose ct,1
2138,loss of chance,1
2139,lopinavir/ ritonavir,1
2140,lung mri,1
2141,lung recruitability,1
2142,lung recruitment,1
2143,mar,1
2144,maternal health,1
2145,maternal,1
2146,mask,1
2147,mas825,1
2148,marshallese,1
2149,marker therapeutics,1
2150,management strategies,1
2151,lupus erythematous disease,1
2152,male reproductive health,1
2153,maldi tof ms,1
2154,m health,1
2155,lymphopenia,1
2156,lymphocytopenia,1
2157,lv dc vaccine,1
2158,lopinavir,1
2159,long term outcomes,1
2160,maternal mortality,1
2161,long term follow up,1
2162,length of stay,1
2163,length of hospitalization,1
2164,left ventricular systolic function,1
2165,left ventricular diastolic function,1
2166,left hemicolectomy,1
2167,"left colon cancer,",1
2168,leflunomide,1
2169,learning in higher education,1
2170,learning autonomy,1
2171,lateral flow assay,1
2172,laser,1
2173,"laparoscopy, prevention",1
2174,laparoscopic left hemicolectomy,1
2175,lansoprazole,1
2176,landscape,1
2177,lentiviral vector,1
2178,"lentiviral vector, covid 19/aapc vaccine",1
2179,less frequency hemodialysis,1
2180,linac,1
2181,long term care home,1
2182,long term care,1
2183,long term / specialized care,1
2184,long term,1
2185,lombardy,1
2186,live biotherapeutic product,1
2187,light and sound stimulation,1
2188,leukine,1
2189,lifestyle habits,1
2190,lifestyle behaviours,1
2191,life change events,1
2192,lianhua qingwen,1
2193,levofloxacin,1
2194,levamisole,1
2195,maternal morbidity,1
2196,maternal respiratory impairment,1
2197,postexposure prophylaxis,1
2198,micro nutrient adequacy,1
2199,"mmr vaccine, respiratory failure,",1
2200,mmr vaccine,1
2201,mitochondrial phenotype,1
2202,mis c,1
2203,minfullness based cognitive therapy,1
2204,mind body therapies,1
2205,mind body intervention,1
2206,military,1
2207,mild to moderate form,1
2208,mild illness,1
2209,middle east respiratory syndrome (mers),1
2210,middle east respiratory syndrome,1
2211,middle aged,1
2212,microvesicles,1
2213,microparticles,1
2214,mobile application,1
2215,mobile internet survey,1
2216,mobile tools,1
2217,morbidity,1
2218,moxifloxacin,1
2219,moxibustion,1
2220,mouthwashes,1
2221,mouth wash,1
2222,mother's anxiety,1
2223,mortality rate,1
2224,moral injury,1
2225,modelisation,1
2226,mood,1
2227,momentasone nasal spray,1
2228,molecular testing,1
2229,moderate disease,1
2230,moderate covid 10,1
2231,moderate,1
2232,microglia,1
2233,michigan,1
2234,mavrilimumab,1
2235,mews,1
2236,medically tailored meals,1
2237,medical yoga pranayama,1
2238,medical workers,1
2239,medical transport by train,1
2240,medical student,1
2241,medical simulation,1
2242,medical sequelae,1
2243,medical rehabilitation,1
2244,medical ozone,1
2245,medical errors,1
2246,medical consultation,1
2247,medical assisted procreation,1
2248,mechanical trombectomy,1
2249,mechanical thrombectomy,1
2250,maxillofacial fractures,1
2251,medication,1
2252,menstrual cycle,1
2253,mental disorder,1
2254,metabolic factors,1
2255,methyprednisolone,1
2256,methylene blue,1
2257,metacognition,1
2258,metabolic syndrome,1
2259,metabolic phenotype,1
2260,metabolic health,1
2261,messaging,1
2262,mental disorders,1
2263,mesenchymal stromal stem cells,1
2264,mesenchymal cells from umbilical cord,1
2265,mers,1
2266,mental well being,1
2267,"mental health, covid 19, pandemic, indonesia",1
2268,mental health outcomes,1
2269,lambda interferon,1
2270,lambda,1
2271,lam 002a,1
2272,immune profile,1
2273,immunomodulation,1
2274,immunological mechanisms,1
2275,immunological function,1
2276,immunologic factors,1
2277,immunologic assessments,1
2278,immunoglubulins,1
2279,"immunoglobulins, intravenous",1
2280,immunoglobulin igm,1
2281,immunoglobulin igg,1
2282,immunoglobulin,1
2283,immunocompromised,1
2284,immuno modulatory,1
2285,immuno modulator,1
2286,"immunity, humoral",1
2287,immune responses,1
2288,immunomodulatory,1
2289,immunomodulatory mesenchymal stem cells,1
2290,immunopsychiatry,1
2291,in vitro diagnostics,1
2292,infections,1
2293,infection viral,1
2294,infection prevention and control,1
2295,infectiology,1
2296,individuals at risk of exposure to sars cov 2,1
2297,inactivated vaccine,1
2298,in hospital screening,1
2299,immunosuppressive,1
2300,in hospital death,1
2301,in hospital cardiac arrest,1
2302,imrcs,1
2303,impressions,1
2304,implementation,1
2305,immunothrombosis,1
2306,immune profiling,1
2307,immune modulation,1
2308,lactococcus lactis w136,1
2309,immature granulocyte percentage,1
2310,igg/igm antibodies,1
2311,igg test,1
2312,igg and igm against sars cov 2,1
2313,iga,1
2314,ifn type1,1
2315,ifn beta,1
2316,icuaw,1
2317,icu capacity,1
2318,icu admission,1
2319,icts,1
2320,icosapent ethyl,1
2321,ibrutinib,1
2322,ibd,1
2323,i/v infusions,1
2324,hypoxic stimulus,1
2325,igm igg,1
2326,igm test,1
2327,igm/igg antibodies,1
2328,ileukpulm,1
2329,immature granulocyte count,1
2330,imflammatory pathway,1
2331,imbruvica,1
2332,imatinib,1
2333,imaging features,1
2334,iloprost,1
2335,ilaris,1
2336,igm/igg serological tests,1
2337,il15 superagonist,1
2338,il 6/il 6 receptor pathway,1
2339,il 6 receptor inhibitors,1
2340,il 12 rb gene polymorphism,1
2341,il 1 inhibitors,1
2342,il 1 beta,1
2343,infertility,1
2344,inflammatory and autoimmune processes,1
2345,inflammatory biomarkers,1
2346,inflammatory cytokine,1
2347,italy,1
2348,italian hematology alliance,1
2349,isotretinoin,1
2350,isoprinosine,1
2351,ischemia,1
2352,iodine complex,1
2353,invasives mycoses,1
2354,invasively ventilated,1
2355,intubation box,1
2356,intubated patients,1
2357,intubated,1
2358,intrusive memories of traumatic event(s),1
2359,intrinsic capacity,1
2360,intravitreal injections,1
2361,intravenous sedation,1
2362,ivd,1
2363,ivermectin carrageenan covid 19,1
2364,jak inhibitors,1
2365,kidney function,1
2366,lactobacillus rhmnosus gg,1
2367,knowledge,1
2368,knee,1
2369,kinin kallikrein system,1
2370,kidney transplants,1
2371,kidney transplant,1
2372,kidney damage,1
2373,jak1,1
2374,"keywords: covid 2019 , isotretinoin, endosomal toll like receptor 3,t cells, ifn type1, at1, ace2,alvelestat",1
2375,ketogenic diet,1
2376,zinc gluconate,1
2377,kawasaki like syndrome,1
2378,janus kinase,1
2379,jak2,1
2380,intravenous insulin,1
2381,intraosseous access,1
2382,intranasal,1
2383,inhalation oxygen therapy,1
2384,inspiratory muscle training,1
2385,inopulse,1
2386,ino 4800,1
2387,innate immunity,1
2388,inhaled steroids,1
2389,inhaled sedation,1
2390,inhalation,1
2391,instructor support,1
2392,informal caregivers,1
2393,informal caregiver,1
2394,influenza,1
2395,infliximab,1
2396,inflammatory phase,1
2397,inflammatory cytokines,1
2398,instant messaging,1
2399,insulin,1
2400,intradomestic contacts,1
2401,international standardization,1
2402,intracorporeal resection and anastomosis,1
2403,intra pulmonary shunt,1
2404,interview,1
2405,intervention,1
2406,internet delivered cognitive behavioral therapy (icbt),1
2407,internet delivered,1
2408,interleukin 2,1
2409,integrated care for older people (icope),1
2410,interferon beta 1b,1
2411,inter observer variability,1
2412,intensive care united,1
2413,intensive care unit nurses,1
2414,intensive care unit acquired weakness,1
2415,intensive care medicine,1
2416,mri,1
2417,mrx 4dp0004,1
2418,msv,1
2419,parainfluenza,1
2420,patient outcome assessment,1
2421,patient management,1
2422,pathomechanisms,1
2423,pathology,1
2424,pathogen inactivation,1
2425,participatory research,1
2426,participants in nih funded studies (and their families),1
2427,"parkinson disease,",1
2428,parents,1
2429,parenting,1
2430,parental stress,1
2431,parent engagement,1
2432,parent child relationship,1
2433,paraphilia,1
2434,paramedics,1
2435,patient registry,1
2436,patient satisfaction,1
2437,patient stratification,1
2438,pediatric emergencies,1
2439,peginterferon lambda 1a,1
2440,peginterferon lambda,1
2441,peer learning,1
2442,peep,1
2443,pediatrics,1
2444,"pediatric oncology, covid 19",1
2445,pediatric department,1
2446,patients,1
2447,peadiarics,1
2448,pd 1,1
2449,pcr,1
2450,pbm,1
2451,paucisymptomatic,1
2452,patients' needs,1
2453,paramedic,1
2454,pantoprazole,1
2455,organ function,1
2456,pandemic 2020,1
2457,oxygen support,1
2458,oxygen supplementation,1
2459,oxygen requirement,1
2460,oxygen ozone therapy,1
2461,oxygen dependence,1
2462,oximeter,1
2463,oxidative stress,1
2464,overweight,1
2465,out patient,1
2466,out of hospital cardiac arrest,1
2467,otitis media with effusion,1
2468,otilimab,1
2469,osteoarthritis,1
2470,oseltamivir,1
2471,orthopaedics,1
2472,oxygen therapy,1
2473,oxygen treatment,1
2474,oxygenation,1
2475,palliative situation,1
2476,pancreatic surgery,1
2477,pancreatic cancer,1
2478,pancreatic adenocarcinoma,1
2479,pancreas transplants,1
2480,pancreas transplant,1
2481,pancreas cancer,1
2482,pakistan,1
2483,oxygenotherapy,1
2484,paediatric,1
2485,pacific islanders,1
2486,p38 mapk inhibitor,1
2487,p2et,1
2488,ozone,1
2489,oxytocin,1
2490,penn state,1
2491,perception,1
2492,perineural block,1
2493,peripheral artery disease,1
2494,"pneumonia, steroid, covid 19, sars cov 2",1
2495,pneumonia covid 19 ventilator dependent,1
2496,pneumology,1
2497,pneumocystosis,1
2498,pnemonia,1
2499,pmsi,1
2500,pm  no2 ozone,1
2501,plitidepsin,1
2502,pleural pressure,1
2503,platform trial,1
2504,platelets functions,1
2505,platelet inhibition,1
2506,platelet disfunction,1
2507,platelet aggreggation,1
2508,plasmapheresis,1
2509,pneumoperitoneum,1
2510,poc,1
2511,point of care (poc) assay,1
2512,positive predictive value,1
2513,posteroanterior,1
2514,post viral anosmia,1
2515,post trauma stress disorder,1
2516,post tramatic stress disorder,1
2517,post surgical work out,1
2518,post icu syndrome,1
2519,positive end expiratory pressure,1
2520,point of care testing,1
2521,positive airway pressure,1
2522,position,1
2523,population screening,1
2524,population,1
2525,police officers,1
2526,point of care ultrasound,1
2527,plasma transfusion,1
2528,plasma therapy,1
2529,plasma hyperimmune,1
2530,pharmacological impact,1
2531,photobiomodulation therapy,1
2532,photobiomodulation,1
2533,phenotype,1
2534,phenolic monoterpenes,1
2535,phase iii,1
2536,phase 1 first in human study,1
2537,pharmacists/ covid 19,1
2538,physical and rehabilitation medicine,1
2539,personnel protective equipment,1
2540,personnel,1
2541,personalized health education,1
2542,personalised nutrition,1
2543,personal protective equipment from biological hazards,1
2544,personal protection,1
2545,photodynamic therapy,1
2546,physical exercise,1
2547,plasma from patients cured,1
2548,piperacillin tazobactam,1
2549,plaquenil,1
2550,placenta derived mmscs,1
2551,placenta,1
2552,placebo,1
2553,piv,1
2554,pittsburgh sleep quality index,1
2555,pics,1
2556,physical functional performance,1
2557,piclidenoson,1
2558,physiological effects of drugs,1
2559,physical rehabilitation,1
2560,physical performance,1
2561,physical inactivity,1
2562,physical health,1
2563,oropharyngeal squamous cell carcinoma,1
2564,organ dysfunction,1
2565,mucormycosis,1
2566,natural history study,1
2567,nephrology,1
2568,neonatal morbidity,1
2569,neonatal,1
2570,nen,1
2571,negative predictive value,1
2572,neem extracts,1
2573,needle stick injuries,1
2574,neck of femur,1
2575,neck inspiratory muscle (=nim),1
2576,nec,1
2577,near infrared light,1
2578,ncov,1
2579,nausea,1
2580,natural language processing,1
2581,natural killer cells,1
2582,nerium oleander,1
2583,nervous system,1
2584,net,1
2585,neurologic function,1
2586,neuromuscular electrical stimulation,1
2587,neuromuscular blockade monitor,1
2588,neuromuscular blockade agent,1
2589,neurological manifestations,1
2590,neurological disease,1
2591,neurologic manifestations,1
2592,neurokinin 1 receptor,1
2593,nets,1
2594,neurofilament protein light,1
2595,neurodegeneration,1
2596,neurocritical care,1
2597,neurocognitive,1
2598,network analysis,1
2599,network,1
2600,natural honey,1
2601,natural herbal medicine,1
2602,organ,1
2603,nasopharyngeal sample,1
2604,muscle ultrasound,1
2605,muscle thickness,1
2606,muscle strength,1
2607,muscle mass,1
2608,multivirus t cell,1
2609,multiple system organ failure,1
2610,multiple sclerosis,1
2611,multiple organ failure,1
2612,multiple myeloma,1
2613,multiplate,1
2614,multiomics,1
2615,multidrug resistant bacteria,1
2616,multicenter cohort study,1
2617,multi month dispensing,1
2618,multi component self care,1
2619,musculoskeletal,1
2620,myalgia,1
2621,myeloid derived suppressor cells,1
2622,nasal irrigation,1
2623,nasopharyngeal,1
2624,nasal swabs,1
2625,nasal swab,1
2626,nasal spray,1
2627,nasal neuroepithelium,1
2628,nasal mucosa cilia (nmc),1
2629,nasal high flow,1
2630,n 3fa,1
2631,naproxen,1
2632,naltrexone,1
2633,na 831,1
2634,n99,1
2635,n1 2c oropharyngeal squamous cell carcinoma,1
2636,n 95,1
2637,neuromuscular function,1
2638,neurotropism of sars cov 2,1
2639,neurourology,1
2640,neutrophils,1
2641,"oise, france",1
2642,off the shelf,1
2643,off target effects,1
2644,ocular inflammation,1
2645,ocular infection,1
2646,oct,1
2647,occupational risk of covid 19,1
2648,occupational life,1
2649,obstructive sleep apnea,1
2650,obstructive jaundice,1
2651,obstetric,1
2652,observational cohort surveillance study,1
2653,obesity counseling,1
2654,nutritional supplement,1
2655,nutritional status,1
2656,olfaction,1
2657,olfactory device,1
2658,olfactory mucosa,1
2659,online resources,1
2660,ordinal scale,1
2661,oral hygiene practice,1
2662,oral health,1
2663,ophthalmological lesions,1
2664,op 101,1
2665,online support,1
2666,online psychotherapy,1
2667,oligosaccharide,1
2668,online,1
2669,on line,1
2670,omeprazole,1
2671,omega 3,1
2672,ome,1
2673,oligosaccharides,1
2674,nutritional risk,1
2675,nursing students,1
2676,nursing home,1
2677,nitrite,1
2678,non hemorrhagic stroke,1
2679,non hematopoietic peripheral blood stem cells,1
2680,nlrp3 inflammasome,1
2681,nkg2d ace2 car nk,1
2682,nk cells,1
2683,niv,1
2684,nitric oxide gas,1
2685,non invasive neuromodulation,1
2686,nirs,1
2687,niclosamide,1
2688,nf kb,1
2689,next generation sequencing,1
2690,news2,1
2691,newborn intensive care,1
2692,non intubated,1
2693,non invasive sensory stimulation,1
2694,nursery,1
2695,nosocomial,1
2696,nt pro bnp,1
2697,novel coronavirus（covid 19）,1
2698,novel coronavirus disease 2019 (covid 19),1
2699,nosocomial infection,1
2700,nosocomial covid 19 incidence,1
2701,nosocomial covid 19,1
2702,norway,1
2703,non pharmacological interventions,1
2704,norovirus,1
2705,nonsteroidal anti inflamatory drug,1
2706,noncommunicable diseases,1
2707,non tuberculous mycobacteria,1
2708,non smoker,1
2709,non pharmacological interventions (npis),1
2710,"1,25 dihydroxyvitamin d3",1
